Guo Shuyuan, Li Luxiao, Yin Huiyong
Key Laboratory of Food Safety Research, Institute for Nutritional Sciences (INS), Shanghai Institutes for Biological Sciences (SIBS), Chinese Academy of Sciences (CAS), Shanghai, China.
University of Chinese Academy of Sciences, CAS, Beijing, China.
Cardiovasc Hematol Disord Drug Targets. 2018;18(1):27-33. doi: 10.2174/1871529X18666180302113713.
Cholesterol is an important lipid for maintaining cell membrane fluidity and generation of various hormones and bile acids. Thus, it is critical to maintain cholesterol homeostasis including absorption, trafficking, biosynthesis, and efflux; dysregulation of cholesterol homeostasis may lead to human disorders such as atherosclerosis. As a cholesterol sensor, nuclear receptor liver X receptor (LXR) is an important factor regulating cholesterol homeostasis. Extensive research has been carried out to examine the roles of LXR in atherosclerosis. In this review, we summarize our current understanding of the mechanisms how LXR regulates cholesterol synthesis, efflux, absorption, and conversion of cholesterol esters to cholesterol in the context of atherosclerosis. In addition, we also discuss the possibility of targeting LXR and cholesterol homeostasis as a potential interventional strategy for treating atherosclerosis.
胆固醇是一种重要的脂质,对于维持细胞膜流动性以及各种激素和胆汁酸的生成至关重要。因此,维持胆固醇稳态(包括吸收、转运、生物合成和流出)至关重要;胆固醇稳态失调可能导致诸如动脉粥样硬化等人类疾病。作为一种胆固醇传感器,核受体肝X受体(LXR)是调节胆固醇稳态的重要因素。人们已经开展了广泛的研究来探究LXR在动脉粥样硬化中的作用。在本综述中,我们总结了目前对于在动脉粥样硬化背景下LXR如何调节胆固醇合成、流出、吸收以及胆固醇酯向胆固醇转化的机制的理解。此外,我们还讨论了将LXR和胆固醇稳态作为治疗动脉粥样硬化的潜在干预策略的可能性。